Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Patent
1993-08-30
1998-12-29
Teng, Sally P.
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
530327, 530395, 435 691, 536 235, C07K 14435
Patent
active
058543929
ABSTRACT:
The present invention relates to the cloning of .beta.APP-C100 receptor (C100-R), and genetically engineered host cells which express the C100-R. Such engineered cells may be used to evaluate and screen drugs and analogs of .beta.-APP involved in Alzheimer's Disease.
REFERENCES:
patent: 4675285 (1987-06-01), Clark et al.
Thomas et al., Methods In Enzymology, vol. 182, 499-505, 1990, Academic Press, Inc.
Kozlowski et al., The Journal of Neuroscience, vol. 12, pp. 1679, 1992.
Gearing et al., The Embo J., vol. 8, pp. 3667, 1989.
Roth, M. et al., 1966, "Correlation Between Scores for Dementia and Counts of `Senile Plaques` in Cerebral Grey Matter of Elderly Subjects" Nature 209:109-110.
Terry, R.D. et al., 1981, "Some Morphometric Aspects of the Brain in Senile Dementia of the Alzheimer Type" Annals of Neurology 10:184-192.
Glenner, G.G., 1983, "Alzheimer's Disease" Arch. Pathol. Lab. Med. 107:281-282.
Schonfeld, A.R. and Katzman, R., 1983, "In Vivo Cholinotrophic Activities" Banbury Report 15, Cold Spring Harbor Lab., Cold Spring Harbor, N.Y.
Glenner, G.G. and Wong, C.W., 1984, "Alzheimer's Disease: Initial Report of the Purification and Characterization of a Novel Cerebrovascular Amyloid Protein" Biochem. Biophs. Res. Comm. 120:885-890.
Masters, C.L. et al., 1985, "Amyloid Plaque Core Protein in Alzheimer Disease and Down Syndrome" Proc. Natl. Acad. Sci. USA 82:4245-4249.
Selkoe, D.J. et al., 1988, ".beta.-Amyloid Precursor Protein of Alzheimer Disease Occurs as 110-to-135-kilodalton Membrane-associated Proteins in Neural and Non-neural Tissues" Proc. Natl. Acad. Sci. USA 85:7341-7345.
Yakner, B.A. et al., 1989, "Neurotoxicity of a Fragment of the Amyloid Precursor Associated with Alzheimer's Disease" Science 245:417-420.
Wolf, D. et al., 1990, "Identification and Characterization of C-terminal Fragments of the .beta.-Amyloid Precursor Produced in Cell Culture" EMBO J. 9:2079-2084.
Maruyama, K. et al., 1990, "Formation of Amyloid-like Fibrils in COS Cells Overexpressing Part of the Alzheimer Amyloid Protein Precursor" Science 347:566-569.
Estus, S. et al., 1992, "Potentially Amyloidogenic, Carboxyl-Terminal Derivatives of the Amyloid Protein Precursor" Science 255:726-728.
Neve, R.L., 1992, "Brain Transplants of Cells Expressing the Carboxyl-terminal Fragment of the Alzheimer Amyloid Protein Precursor Cause Specific Neuropathology In Vivo" Proc. Natl. Acad. Sci. USA 89:3448-3452.
Iacopino, A. et al., 1992, "Calbindin-D.sub.28K -containing Neurons in Animal Models of Neurodegeneration: Possible Protection From Excitotoxicity" Mol. Brain Res. 13:251-261.
Mattson, M.P. et al., 1992 ".beta.-Amyloid Peptides Destabilize Calcium Homeostatis and Render Human Cortical Neurons Vulnerable to Excitotoxicity" J. Neuroscience 12:376-389.
Joseph, R. and Han, E., 1992, "Amyloid .beta.-Protein Fragment 25-35 Causes Activation of Cytoplasmic Calcium in Neurons" Biochem. Biophys. Res. Comm. 184:1441-1447.
Kozlowski Michael R.
Manly Susan P.
Neve Rachael L.
Bristol--Myers Squibb Company
McLean Hospital Corporation
Teng Sally P.
LandOfFree
.beta. APP-C100 receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with .beta. APP-C100 receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and .beta. APP-C100 receptor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1425853